加州大学旧金山分校的研究人员发现，10% 的多发性硬化症患者具有独特的自身抗体特征，这可能有助于早期诊断和治疗。 10% of multiple sclerosis patients have unique autoantibody signature discovered by UC San Francisco researchers, potentially enabling early diagnosis and treatment.
加州大学旧金山分校的研究人员在大约 10% 的多发性硬化症患者出现症状前几年就发现了独特的自身抗体特征。 Researchers at UC San Francisco discover a unique autoantibody signature in about 10% of multiple sclerosis patients years before the onset of symptoms. 这一突破有可能实现早期诊断和治疗，改善每年数千名多发性硬化症患者的生活。 This breakthrough could potentially lead to early diagnosis and treatment, improving the lives of thousands of patients diagnosed with MS each year. 很快就能实现通过简单的血液检测来检测这些自身抗体，从而能够更早地干预和更好地管理疾病。 A simple blood test detecting these autoantibodies may soon be available, enabling earlier intervention and better management of the disease.